demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 all comersCOVID-19 mild to moderate
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderate
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies Malgorzata
anti GM-CSF
mavrilimumab MASH-COVID ...
clarithromycine Tsiakos Rashad ...
colchicine COLCOVID Scarsi Lopes MIF Salehzadeh GRECCO-19 RECOVERY ... Horby Sandhu COL-COVID ...
Colchicine plus rosuvastatin COLSTAT Gaitan-Duarte ...
non-steroidal anti-inflammatory drugs Jeong Bruce Imam Drake Guzman-Esquivel
Celecoxib Wenxin
Indomethacin Ravichandran Ravichandran
stem cells Lanzoni Carmenate ...
corticosteroids Fernández Cruz GLUCOCOVID Rahman Albani SAM-COVID-19 Rodriguez-Bano ... Rodriguez-Bano ... Li ... Majmundar
dexamethasone RECOVERY dexamethasone
methylprednisolone Tang X Metcovid Ranjbar
Immunostimulants drugs
convalescent plasma treatment ConCOVID ... Abolghasemi Salazar ConPlas-19 COP-COVID-19 CONTAIN COVID-19 PC/COVID-19 NCT04397757 PLACO-COVID CONCOR-1 CPC-SARS NCT04442191 DAWN-Plasma NCT04385199 COPLA-II trial NCT04403477 ... ASCOT RECOVERY ... CONFIDENT PERUCONPLASMA Bennett-Guerrero Salman Kirenga LACCPT Co-CLARITY NCT04528368 Holm K CCAP-2 Baldeon Menichetti LIFESAVER PLACID Libster
Early convalescent plasma. Balcells
immunoglobulin therapy Sakoulas Parikh
interferon Wang ... Wang Cai -FAVIPIRAVIR Cai -FAVIPIRAVIR
IFN beta-1a SOLIDARITY ...
high-dose IFN beta-1a Darazam
IFN gamma Esquivel-Moynelo
inhaled interferon
IFN alpha
pegylated interferon-α2b Pandit Shashi Bhushan
recombinant super-compound interferon rSIFN-co Li
SNG001 inhaled interferon beta Synairgen SG016 SPRINTER
interferon / TFF2 Fu
peginterferon Jagannathan
PNB001 Lattmann
neutralizing antibody ITAC
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences) ACTIV-3 ...
bamlanivimab monotherapy ACTIV-3/TICO LY-CoV555
casirivimab/imdevimab (Ronapreve) RECOVERY ... Somersan-Karakaya ... Suzuki
cilgavimab and tixagevimab (Evusheld) ACTIV-3/TICO ... Chen
sotrovimab (Xevudy; VIR-7831) ACTIV-3/ TICO ...
Immunosuppressants drugs
anakinra SAVE-MORE CORIMUNO-ANA-1
anti-interleukin-6
sarilumab CORIMUNO-SARI-1 ...
sarilumab high dose (400mg) sarilumab phase 2 high dose
sarilumab low dose (200mg) sarimulab phase 2 low dose
tocilizumab Dongsheng Wang RCT-TCZ-COVID-19 Martinez-Sanz HNF Hospital Tocilizumab multidisciplinary team Colaneri EMPACTA Tsai SAM-COVID-19 RECOVERY Soin AS ... Rutgers NCT04412772 ... Declercq J ... NCT04577534 ... EU-CTR2020-001375-32 ... EU-CTR2020-001748-24 ... NCT04479358 ... NCT04434717 ... TOCOVID BACC Bay Tocilizumab Trial Capra
canakinumab Sheng ...
janus kinase (JAK) inhibitor
baricitinib COV-BARRIER ACTT-2 ... RECOVERY Rodriguez-Garcia Cantini
tofacitinib STOP-COVID ... Murugesan
lenzilumab LIVE-AIR ...
Kinase inhibitors
acalabrutinib CALAVI CALAVI US
imatinib Covid-19 HUF
leflunomide Wang et al. Wang

0 studies excluded by filtering options 2